Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 2/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.35 |
| ▸ | DCUN1D2 | Q6PH85 | 1/20 | 0.34 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12207340 | 1.00 | ADK (0.39) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL6725763 | 1.00 | ADK (0.39) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL12690594 | 0.98 | ADK (0.38) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL6725276 | 0.98 | ADK (0.38) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL6725288 | 0.98 | ADK (0.38) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL6725006 | 0.92 | ADK (0.41) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL12207335 | 0.92 | ADK (0.41) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL12207690 | 0.92 | ADK (0.41) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL6725793 | 0.90 | ADK (0.40) | ADKPSMB5L3MBTL1KDM4ETDP1 | |
| SCHEMBL12207692 | 0.90 | ADK (0.40) | ADKPSMB5L3MBTL1KDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2004616-B1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2014-05-21 | — | — | EP | disclosed |
| US-8471017-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO. LTD. (JP) | 2013-06-25 | — | — | US | disclosed |
| US-8471017-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO. LTD. (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20110248254-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-10-13 | — | — | US | disclosed |
| US-20110248254-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-10-13 | — | — | US | disclosed |
| US-8008489-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-8008489-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-20100141130-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20100141130-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-7696348-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORIES CO., LTD. (JP) | 2010-04-13 | — | — | US | disclosed |
| WO-2007108403-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-09-27 | — | — | WO | disclosed |
| US-20070222374-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100141130-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE USING THE QUINOXALINE DERIVATIVE | NDUFA9, MT-ND1, NQO2 | ADK 2682/4885PSMB5 3272/4885L3MBTL1 1414/4885 |
| US-20070222374-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative | NDUFA9, MT-ND1, NQO2 | ADK 2682/4885PSMB5 3272/4885L3MBTL1 1414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.